New radioligand therapy (RLT) for solid tumors

• Unité de recherche: INNOSUISSE
• Numéro de projet: 114.709 IP-LS
• Titre du projet anglais: New radioligand therapy (RLT) for solid tumors

Mots-clé (Anglais)

Life sciences, Pharmaceuticals

Résumé des résultats (Abstract) (Anglais)

We develop a radioligand therapy at a novel target for colorectal cancer, one of the most prevalent cancers worldwide. Feasibility studies executed in a collaboration of PSI and Amphilix AG already demonstrated high target affinity and selective uptake to tumours in mice for the lead candidate.